Cover Image

The HIV-1 antisense transcript AST recruits the polycomb repressor complex 2 to the HIV-1 5'LTR and acts as a viral latency factor

Saved in:

Bibliographic Details
Main Authors:	F. Romerio (Author), J.C. Zapata (Author), R. Barclay (Author), M.D. Iglesias-Ussel (Author), F. Kashanchi (Author)
Format:	Book
Published:	Elsevier, 2017-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The HIV-1 antisense transcript AST is an inducer of viral latency
by: F. Romerio, et al.
Published: (2015)

PP 1.28 - 00156 The HIV-1 antisense RNA Ast promotes viral latency via epigenetic silencing of the proviral 5'LTR and is expressed in latently infected cells from ART-suppressed donors
by: F. Romerio, et al.
Published: (2022)

Interactions with pathogenic bacteria induce HIV-1 latency in macrophages through altered transcription factor recruitment to the LTR
by: T. Hanley, et al.
Published: (2019)

DNA-PK regulates HIV transcription and latency by supporting the activity of RNA polymerase II and the recruitment of transcription machinery at HIV LTR
by: M. Tyagi, et al.
Published: (2017)

Multiple NF-κB elements in the LTR of HIV-1 subtype C coordinate with the auto-regulatory circuit of Tat to drive rapid establishment of latency
by: S. Chakraborty, et al.
Published: (2017)

SNPs within the HIV-1 LTR associate with increased virus persistence
by: N.T. Sullivan, et al.
Published: (2015)

Detection and enrichment to near purity of rare HIV-1 infected cells by PrimeFlow RNA
by: F. Romerio, et al.
Published: (2015)

The Polycomb protein, Bmi1, regulates insulin sensitivity
by: Corey E. Cannon, et al.
Published: (2014)

Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019)

Effect of Xanthium Strumarium on HIV-1 5'-LTR Transcriptional Activity and Viral Reactivation in Latently Infected Cells
by: Chao-Jung Chen, et al.
Published: (2021)

PP 3.14 - 00190 Ex vivo response to latency reversal agents of CD4+ T cell subsets and monocyte derived HIV-1 subtype C LTR from individuals on suppressive cART
by: K. Gopee, et al.
Published: (2022)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies
by: A. Allen, et al.
Published: (2017)

20 Sirtuin1 inhibitor nicotinamide disrupts HIV-1 latency
by: S. Samer, et al.
Published: (2016)

Novel use of alprazolam as a potential HIV-1 latency reversing agent
by: W. Elbezanti, et al.
Published: (2017)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

Influence of SULT1A1&ast;2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients
by: Chamnanphon M, et al.
Published: (2021)

HIV-1 transcriptional latency in resting CD4 T-cell
by: M. Benkirane
Published: (2015)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

Broad-spectrum gRNAs abolish HIV-1 LTR-mediated transcription in cells that receive CRISPR/Cas9 therapy
by: B. Wigdahl, et al.
Published: (2019)

10 The interferon-inducible restriction factor TRIM22 contributes to HIV-1 latency
by: F. Turrini, et al.
Published: (2016)

Polycomb protein RYBP facilitates super-enhancer activity
by: Yu Hong, et al.
Published: (2024)

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection
by: Suha Saleh, et al.
Published: (2017)

Human endogenous retrovirus expression landscape in models of HIV-1 latency
by: M. de Mulder Rougvie, et al.
Published: (2019)

Integration site-independent enhancement of latency reversal by HIV-1 Nef
by: X.T. Kuang, et al.
Published: (2017)

The role of miR-29a in HIV-1 replication and latency
by: Giacomo Frattari, et al.
Published: (2017)

Lack of transcriptional latency in infected primary cells in the presence of exosomes and cART
by: C. DeMarino, et al.
Published: (2017)

cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells
by: Anupam Banerjee, et al.
Published: (2017)

PP 1.4 - 00037 Histone decrotonylation uniquely regulates HIV-1 transcription and can be modulated to control HIV-1 latency
by: T.L. Simermeyer, et al.
Published: (2022)

O7 Implication of DNA methylation in HIV-1 post-integration latency.
by: Roxane Verdikt, et al.
Published: (2016)

PP 5.4 - 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents
by: L. Pache, et al.
Published: (2022)

Towards achieving a state of reversible HIV-1 latency in primary monocyte-derived macrophages (MDM) by M1 polarization
by: G. Poli, et al.
Published: (2015)

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
by: Cheng-Han Chung, et al.
Published: (2020)

Croton oligandrus Pierre & Hutch (Euphorbiaceae) Extracts and Isolated Compounds Reverse HIV-1 Latency
by: Emade Nkwelle C, et al.
Published: (2024)

PP 1.1 - 00009 TB-associated microenvironment promotes HIV latency in CD4+ T cells
by: G. Duette, et al.
Published: (2022)

PP 1.11 - 00075 Selective nuclear retention of spliced and unspliced HIV-1 mRNAs following latency reversal
by: E. Honeycutt, et al.
Published: (2022)

Degradation of the XPB subunit of TFIIH by spironolactone reduces HIV-1 reactivation from latency
by: L. Mori, et al.
Published: (2019)

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure
by: Michaela Madlenakova, et al.
Published: (2017)

Developing an in vitro model for HIV-1 latency in Tfh cells using tonsillar tissue
by: B. Luttge, et al.
Published: (2017)

Latency reactivating agents: impact on human macrophages physiology and susceptibility to HIV-1 infection
by: L. Hany, et al.
Published: (2019)